The 2024 U.S.-Taiwan Patient Care Innovation Forum, co-hosted by AmCham Taiwan and AIT, showcased significant advancements in healthcare technology, including expanded hemodialysis, IMVAD for heart failure, and precision radioligand therapy. Keynote speakers emphasized the need for evolving policies to support these innovations and align with Taiwan’s healthcare goals.
Taiwan’s new government is spearheading the “Healthy Taiwan” initiative to revamp the nation’s healthcare system with ambitious goals, including reducing cancer deaths by a third by 2030 and improving access to cutting-edge treatments. The plan involves increasing early disease detection, integrating new cancer drugs into the National Health Insurance (NHI), and enhancing overall health care services without overextending the NHI’s budget. Key elements include a comprehensive health exam for citizens, telemedicine, and a significant fund dedicated to advanced cancer treatments.
The Lai administration has bold ambitions for supporting cancer patients, but many details about the plan still remain uncertain. President Lai Ching-te gained widespread public interest during his election campaign last year by announcing his “Healthy Taiwan” policy focusing on disease prevention and health maintenance. The cornerstone of the plan is the establishment of a…
The American Chamber of Commerce in Taiwan hosted its 2024 Cancer Summit on July 15 at the Regent Taipei, attracting prominent members from the healthcare industry. The event, titled “Blueprint for a Comprehensive Cancer Drugs Fund,” served as a thorough examination and careful forecast of President Lai Ching-te’s well-underway Taiwan multi-support Cancer Drugs Fund (TmCDF),…
Lung cancer remains the leading cause of cancer mortality in Taiwan, with the five-year survival rate for advanced stages lingering around 10%. Despite significant advances in medical technology and treatment protocols worldwide, Taiwan faces a critical gap in aligning its National Health Insurance reimbursement with international standards for lung cancer treatment. “Despite some progress in…
Extending free vaccination to males could reduce the spread of the human papilloma virus, which is the primary cause of both cervical and oropharyngeal cancer. The human papilloma virus (HPV) is a leading cause of several types of cancer. The World Health Organization (WHO) estimates that two types of HPV (16 and 18) cause 70%…
Despite a successful national screening program, the incidence of colorectal malignancies has not significantly decreased in recent years. Colorectal cancer has been among the most common malignancies in Taiwan for more than a decade, and it has had a relatively high mortality rate. About 15,000 people are diagnosed with the disease in Taiwan every year,…
The company hopes to benefit citizens and shed new light on the treatment of cancer. Pfizer Taiwan and the National Health Research Institutes (NHRI), along with two other partnering companies, recently signed a precision medicine cooperation alliance agreement, officially launching a joint initiative to develop precision cancer treatments in Taiwan. The agreement commits all parties…
Lung cancer is the deadliest form of cancer in Taiwan. More than 9,700 Taiwanese die from the disease in 2018, yet Taiwan still struggles to reduce the mortality rate from this devastating illness. In fact, the Executive Yuan’s Golden Ten-Year Plan, launched in 2010, aimed to decrease Taiwan’s standardized cancer mortality rates by 20%, but…
With the mission of creating “a world without fear of cancer,” Varian Medical Systems has been a leader in oncology research for the past 70 years.
